AIM
IRMD icon

Acrospire Investment Management’s iRadimed IRMD Stock Holding History

Acrospire Investment Management’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-636
Closed -$7K – 2336
2016
Q4 		$7K Sell
636
-2,227
-78% -$24K ﹤0.01% 2013
2016
Q3 		$49K Sell
2,863
-400
-12% -$7.41K 0.03% 1083
2016
Q2 		$71K Buy
3,263
+2,812
+624% +$50.6K 0.05% 781
2016
Q1 		$9K Buy
+451
New +$8.63K 0.01% 1767

Other funds holding IRMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return
MERSOM
Municipal Employees' Retirement System of Michigan Lansing, Michigan $8.81B AUM 10.88% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MC
Menta Capital San Francisco, California $236M AUM 6.6% 1-Year Est. Return

Acrospire Investment Management's IRMD Position: Q1 2017 in Review

Acrospire Investment Management sold out of iRadimed (IRMD) in Q1 2017, closing a stake of 636 shares — an estimated $7K sold.

Acrospire Investment Management first reported a position in IRMD in Q1 2016 and held it in 4 quarters. The position peaked at $71K in Q2 2016. 46 funds tracked by Wall St. Rank hold IRMD as of Q1 2017.

  • Acrospire Investment Management reported no remaining iRadimed position as of Q1 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 636 iRadimed shares in Q1 2017, an estimated $7K.
  • Acrospire Investment Management first reported a position in iRadimed in Q1 2016 and held it in 4 quarters.
  • Acrospire Investment Management's iRadimed position peaked at $71K in Q2 2016.
  • 46 funds tracked by Wall St. Rank held iRadimed as of Q1 2017.

Based on Acrospire Investment Management's 13F filing for Q1 2017, filed 4 May 2017.